Her2-negative breast cancer
Questions discussed in this category
Would you ever consider using these in sequence?
Should this be sent on initial biopsy or on surgical pathology? What if an initially high risk patient has good risk findings post-operatively?What ha...
Are there factors to explain why MonarchE was a positive study and PALLAS was not?
Can you use 50mg BID if intolerant to 150mg and 100mg dosing? Any tips for side effect management to help patients stay on full duration?
Majority of patients on MonarchE received neoadjuvant/adjuvant chemo.
Does the availability of abemaciclib impact your decision to offer chemo ...
MonarchE shows statistically significant improvement in IDFS and DRFS, but the magnitude of absolute benefit is modest (3-year IDFS and DRFS rates = 5...
High-risk criteria meaning >4 positive nodes and Ki67 >20%
1133411321115961125811316113141134211121
Papers discussed in this category
J. Clin. Oncol., 2020 Sep 20
Clin Cancer Res, 2017 Mar 07
Lancet Oncol, 2019 Dec 11
Annals of Oncology, 2021 Sep 29
Ann Oncol,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-09-01
Journal of the National Cancer Institute, 2011-11-16
Archives of pathology & laboratory medicine, 2016-01
Lancet Oncol,
J Clin Oncol, 2009 Apr 20
Clin Cancer Res,
N Engl J Med, 2021 Jun 03